{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:07:15Z","timestamp":1779300435013,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,3]],"date-time":"2026-12-03T00:00:00Z","timestamp":1796256000000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32GM144274"],"award-info":[{"award-number":["T32GM144274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.amjsurg.2025.116761","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:42:43Z","timestamp":1764290563000},"page":"116761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Resected intrahepatic cholangiocarcinoma: Is adjuvant chemotherapy associated with improved overall survival?"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9812-6109","authenticated-orcid":false,"given":"R.L.","family":"Wolansky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sujka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjsurg.2025.116761_bib1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116761_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"11","key":"10.1016\/j.amjsurg.2025.116761_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.hpb.2023.06.019","article-title":"Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma","volume":"25","author":"Olthof","year":"2023","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116761_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.21037\/jgo.2017.11.06","article-title":"Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States","volume":"9","author":"Altman","year":"2018","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.amjsurg.2025.116761_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116761_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2025.116761_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejca.2017.05.006","article-title":"Matching genomic molecular aberrations with molecular targeted agents: are biliary tract cancers an ideal playground?","volume":"81","author":"Verlingue","year":"2017","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.amjsurg.2025.116761_bib8","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1245\/s10434-014-4275-4","article-title":"Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma","volume":"22","author":"Sur","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2025.116761_bib9","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1245\/s10434-015-4501-8","article-title":"Chemotherapy for surgically resected intrahepatic cholangiocarcinoma","volume":"22","author":"Miura","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116761_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.21037\/hbsn.2019.06.12","article-title":"Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?","volume":"9","author":"Altman","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"12","key":"10.1016\/j.amjsurg.2025.116761_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (klatskin tumors) on the incidence of Intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.amjsurg.2025.116761_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evidence"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961025005847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961025005847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:26:59Z","timestamp":1779298019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961025005847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":12,"alternative-id":["S0002961025005847"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116761","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resected intrahepatic cholangiocarcinoma: Is adjuvant chemotherapy associated with improved overall survival?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116761"}}